148 related articles for article (PubMed ID: 11282980)
21. Homeostatic regulation of CD8+ T cells by perforin.
Kägi D; Odermatt B; Mak TW
Eur J Immunol; 1999 Oct; 29(10):3262-72. PubMed ID: 10540338
[TBL] [Abstract][Full Text] [Related]
22. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
23. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
24. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
[TBL] [Abstract][Full Text] [Related]
25. Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli.
Garcia-Sanz JA; Velotti F; MacDonald HR; Masson D; Tschopp J; Nabholz M
Immunology; 1988 May; 64(1):129-34. PubMed ID: 3260214
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
Lancki DW; Hsieh CS; Fitch FW
J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
[TBL] [Abstract][Full Text] [Related]
27. Cytolytic effector function is present in resting peripheral T lymphocytes.
Geisberg M; Dupont B
Int Immunol; 1992 Nov; 4(11):1273-81. PubMed ID: 1472478
[TBL] [Abstract][Full Text] [Related]
28. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
29. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C delta localizes to secretory lysosomes in CD8+ CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity.
Ma JS; Haydar TF; Radoja S
J Immunol; 2008 Oct; 181(7):4716-22. PubMed ID: 18802074
[TBL] [Abstract][Full Text] [Related]
31. Altered effector responses of H-Y transgenic CD8+ cells.
Arsov I; Vukmanović S
Int Immunol; 1997 Oct; 9(10):1423-30. PubMed ID: 9352347
[TBL] [Abstract][Full Text] [Related]
32. Activated alpha beta-CD8+, but not alpha alpha-CD8+, TCR-alpha beta+ murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity.
Gelfanov V; Gelfanova V; Lai YG; Liao NS
J Immunol; 1996 Jan; 156(1):35-41. PubMed ID: 8598484
[TBL] [Abstract][Full Text] [Related]
33. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini JC; Luescher IF
J Immunol; 1998 Dec; 161(12):6939-46. PubMed ID: 9862728
[TBL] [Abstract][Full Text] [Related]
34. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
[TBL] [Abstract][Full Text] [Related]
37. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
38. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
Smith DJ; McGuire MJ; Tocci MJ; Thiele DL
J Immunol; 1997 Jan; 158(1):163-70. PubMed ID: 8977187
[TBL] [Abstract][Full Text] [Related]
39. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
[TBL] [Abstract][Full Text] [Related]
40. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD
J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
